Global Upfront Newspapers
Uncategorized

Oxford COVID-19 vaccine developer cautious on 2020 rollout

Possible vaccine still needs to be proven to work in late-stage trials

Thomson Reuters · Posted: Jul 21, 2020

Samples from coronavirus vaccine trials are handled inside the Oxford Vaccine Group laboratory in Oxford, England, on June 25. (John Cairns, University of Oxford/The Associated Press)

The University of Oxford’s possible COVID-19 vaccine could be rolled out by the end of the year but there is no certainty, the lead developer of the vaccine said on Tuesday.

The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of 2020.

“The end-of-the-year target for getting vaccine rollout, it’s a possibility but there’s absolutely no certainty about that, because we need three things to happen,” Sarah Gilbert told BBC Radio.

She said it needed to be shown to work in late-stage trials, large quantities needed to be manufactured and regulators had to agree quickly to license it for emergency use before large numbers of people could be vaccinated.

Split opinions

England’s Chief Medical Officer Chris Whitty and his deputy, Jonathan Van-Tam, took differing views on the potential timeline.

“The chances of us getting a vaccine before Christmas that actually is highly effective are, in my view, very low,” Whitty told lawmakers.

Van-Tam, however, said he was “cautiously optimistic that we will have some vaccine this side of Christmas.”

The Oxford scientists had eyed a million doses of the potential vaccine to be produced by September.

Although the deal with AstraZeneca has provided manufacturing capacity to do that, the lower prevalence of the novel coronavirus in Britain has complicated the process of proving its efficacy.

Late-stage trials crucial for providing data are underway in Brazil and South Africa and are due to start in the United States.

There are no approved vaccines yet for COVID-19, but the World Health Organization has said AstraZeneca’s shot is one of the leading candidates.

Advertize With Us

See Also

Army moves 26 UN, other humanitarian workers rescued from Dikwa, to Maiduguri

Global Upfront

10 black foods that are healthier than Superfoods

Global Upfront

Ganduje quickly jets out of Benin as Buhari, Ize-Iyamu, Secondus, Obi congratulates Obaseki

Global Upfront

Chinese envoy meets Buhari, canvass increased investment, shared experience with Nigeria

Global Upfront

‘They pointed their guns at us and started shooting,’ CNN investigations on Lekki Tollgate EndSARS protests’ shooting

Global Upfront

Hushpuppi paid Abba Kyari N8 million to arrest and detain a “co-conspirator,” Chibuzo Kelly Vincent, FBI alleges

Global Upfront

Americans are renouncing U.S. citizenship in record numbers – but maybe not for the reasons you think

Global Upfront

Where COVID-19 has left Nigeria’s health system

Global Upfront

Military clears Northern cattle and foodstuff sellers at Kaduna-Jebba Niger bridge enforcing strike on ferrying goods to Southern Nigeria

Global Upfront

Gunmen Blow Up Catholic Church in Taraba State, North East Nigeria

Global Upfront

This website uses Cookies to improve User experience. We assume this is OK...If not, please opt-out! Accept Read More